Pediatric stroke: Current developments

Current Opinion in Pediatrics

Volumn 19, Issue 6, 2007, Pages 657-662

  Seidman, Carly ^a,b   Kirkham, Fenella ^c   Pavlakis, Steven ^b  

^a BROWN UNIVERSITY   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Arterial ischemic stroke; Pediatrics; Prevention; Risk factors; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; DISUFENTON SODIUM; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYUREA; LIPOPOLYSACCHARIDE; LOW MOLECULAR WEIGHT HEPARIN; NITRIC OXIDE; STEROID; WARFARIN;

ANEMIA; ANTICOAGULANT THERAPY; ARTERY DISSECTION; AUTOREGULATION; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE ASSOCIATION; GENETIC RISK; GENETICS; HEART DISEASE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOXIA; INFECTION; MOYAMOYA DISEASE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; SEPSIS; SICKLE CELL ANEMIA; SLEEP APNEA SYNDROME; THROMBUS; VASCULAR DISEASE;

ANEMIA, SICKLE CELL; ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CHILD; HUMANS; HYPERTENSION; RECURRENCE; RISK FACTORS; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 36348953858     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3282f1883b     Document Type: Review

References (59)

1. World Health Organization. Cerebrovascular disorders: a clinical and research classification. Offset publication no. 43. Geneva: WHO; 1978.
2. Lee BCP, Park TS, Kaufman BA. MR angiography in paediatric radiological disorders. Pediatr Radiol 1995; 25:409-419.
3. Laugesaar R, Kolk A, Tomberg T, et al. Acutely and retrospectively diagnosed perinatal stroke: a population-based study. Stroke 2007; 38:2234-2238.
4. DeVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000; 15:316-324.
5. Danchaivijitr N, Cox TC, Saunders DE, Ganesan V. Evolution of cerebral arteriopathies in childhood arterial ischemic stroke. Ann Neurol 2006; 59:620-626.
6. Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 2006; 114:2170-2177. This paper provides data on risk factors for stroke recurrence and emphasizes the role of vasculopathy, genetic thrombophilia, and chronic infection; this information is important in developing secondary prevention strategies.
7. Fullerton HJ, deVeber G. Practice variability in the treatment of childhood acute ischemic stroke: results of the International Pediatric Stroke Study (IPSS) [abstract]. Stroke 2007; 38:485.
8. Earley CJ, Kittner SJ, Feeser BR. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998; 51:169-176.
9. Kirkham FJ. Therapy insight: stroke risk and its management in patients with sickle cell disease. Nat Clin Pract Neurol 2007; 3:264-278.
10. Kirkham FJ, Calamante F, Bynevelt M, et al. Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol 2001; 49:477-485.
11. Fullerton HJ, Wu YW, Sidney S, Johnston SC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007; 119:495-501. Fullerton and colleagues emphasize the association between vasculopathy and stroke recurrence and the role of cerebrovascular imaging. The presence of vasculopathy might confer a higher risk of recurrence and might be used as a marker for at-risk patients who require intervention for the prevention of a secondary recurrence.
12. Dobson SR, Holden KR, Nietert PJ. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002; 99:3144-3150.
13. Braun KP, Rafay MF, Uiterwaal CS, et al. Mode of onset predicts etiological diagnosis of arterial ischemic stroke in children. Stroke 2007; 38:298-302.
14. Kupferman JC, Singh AS, Pavlakis SG. Lacunar stroke and masked hypertension in an adolescent male. Pediatr Neurol 2007; 36:125-127. This case study suggests that hypertension may be a risk factor, previously underestimated, in pediatric AIS (especially lacunar infarct). Kupferman and colleagues underscore the potential importance of examining for hypertension, which might initially be masked. This paper suggests that hypertension might be a greater risk factor for stroke in children than previously recognized and suggests the need for prospective studies.
15. Weisfelt M, Determann RM, Gans J, et al. Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitis. J Infect 2007; 54:545-550.
16. Miravet E, Danchaivitjitr N, Basu H. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol 2007; 49:417-422. Based upon a retrospective review, this paper suggests that varicella zoster virus infection may be a risk factor for developing stroke in the pediatric population.
17. Jordan LC, van Beek JG, Gottesman RF, et al. Ischemic stroke in children with critical illness: a poor prognostic sign. Pediatr Neurol 2007; 36:244-246.
18. Lin Jainn-Jim, Min-Liang C, Lin K. Cerebral infarct secondary to traumatic carotid artery dissection. Pediatr Emerg Care 2007; 23:166-168.
19. Kirton A, DeVeber G. Ischemic stroke complicating pediatric cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007; 4:163-166.
20. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006; 107:2279-2285. This paper is one of many recent genetic studies of adult stroke; a similar study is lacking in the realm of pediatric stroke.
21. Hoppe C, Klitz W, Cheng S, Apple R. Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004; 103:2391-2396.
22. Sebastiani P, Ramoni M, Nolan V, et al. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 2005; 37:425-440.
23. Pavlakis SG, Verlander PC, Gould RJ, et al. Fanconi anemia and moyamoya: evidence for an association. Neurology 1995; 45:998-1000.
24. Yonekawa Y, Ogata N, Kaku Y, et al. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997; 99 (Suppl 2):S58-S60.
25. Soriani S, Scarpa P, Voghenzi A, et al. Moyamoya disease in childhood: a familial case report. Childs Nerv Syst 1993; 9:215-219.
26. Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006; 77:1025-1029.
27. Klein A, Fasnacht M, Thierry AGM. Siblings with infantile cerebral stroke and delayed multivessel involvement - a new hereditary vasculopathy. Eur J Paediatr Neurol 2007; 11:292-296. This case study examined an unusual vasculopathy present in two siblings and suggests that vasculopathy - a risk factor in stroke recurrence - may have a genetic basis. More detailed genetic studies have been done in pediatric SCD; see [22]. Similar genetic influences may also be at play in non-SCD AIS.
28. Voetsch B, Jin RC, Bierl C. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007; 38:41-49. One of the few genetic papers in the field, this paper implicates a gene involved in nitric oxide regulation as a possible risk factor in pediatric AIS.
29. Maguire J, deVeber G, Parkin PC. The association between iron deficiency anemia and stroke in young children. J Pediatr 2007; in press.
30. Kirkham FJ, Hewes DKM, Hargrave D, et al. Nocturnal hypoxaemia predicts CNS events in sickle cell disease. Lancet 2001; 357:1656-1659.
31. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002; 109:116-123.
32. Kuluz JW, Prado R, He D. New pediatric model of ischemic stroke in infant piglets by photothrombosis: acute changes in cerebral blood flow, microvasculature, and early histopathology. Stroke 2007; 38:1932-1937.
33. Prohovnik I, Pavlakis SG, Piomelli S, et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology 1989; 39:344-348.
34. Baldeweg T, Hogan AM, Saunders DE, et al. Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol 2006; 59:662-672.
35. Prengler M, Pavlakis SG, Boyd S. Sickle cell disease: ischemia and seizures. Ann Neurol 2005; 58:290-302.
36. Zimmerman SA, Schultz WH, Burgett S, et al. Hydroxyurea therapy lowers transcranial doppler flow velocities in children with sickle cell anemia. Blood 2007; 110:1043-1047. Zimmermann and colleagues suggest that hydroxyurea therapy may decrease elevated TCD flow velocities in pediatric SCD patients, which may have implications for primary prevention. This also speaks to the fact that hydroxyuria, which increases hematocrit and thereby normalizes cerebral circulation, has therapeutic implications, since vasodynamic issues are important in SCD-associated stroke.
37. Lee MT, Piomelli S, Granger S, et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow up and final results. Blood 2006; 108:847-852.
38. Babikian VL, Feldmann E, Wechsler LR. Transcranial Doppler ultrasonography: year 2000 update. J Neuroimaging 2000; 10:101-115.
39. Ausavarungnirun P, Sabio H, Tegeler CH. Dynamic vascular analysis shows a hyperemic flow pattern in sickle cell disease. J Neuroimaging 2006; 16:311-317. This paper suggests that metabolic hyperemia, rather than intracranial stenosis and a siphon effect, may be the cause of high CBF in SCD.
40. Abboud MR, Cure J, Granger S, et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004; 103:2822-2826.
41. Settakis G, Pall D, Molnar C, et al. Cerebrovascular reactivity in hypertensive and healthy adolescents: TCD with vasodilatory challenge. J Neuroimaging 2003; 13:106-112.
42. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimalmedial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111:61-66.
43. Zimmerman C, Wimmer M, Haberl RL. L-Arginine-mediated vasoreactivity in patients with a risk of stroke. Cerebrovasc Dis 2004; 17:128-133.
44. Morris CR, Vichinsky EP, van Warmerdam J, et al. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol 2003; 25:629-634.
45. Kirkham FJ, DeBaun MR. Stroke in children with sickle cell disease. Curr Treat Options Neurol 2004; 6:357-375.
46. Hickey EJ, Xiaomang Y, Kaimaktchiev V, et al. Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2007; 133:1588-1596.
47. Ballerini L, Cifarelli A, Ammirati A, Gimigliano F. Patkkent foramen ovale and cryptogenic stroke: a critical review. J Cardiovasc Med 2007; 8:34-38.
48. Tripathi P, Tripathi V, Naik RJ, Patel JM. Moya moya cases treated with encephaloduroarteriosynangiosis. Indian Pediatr 2007; 44:123-127.
49. Kim DS, Kang SG, Yoo DS, et al. Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results. Clin Neurol Neurosurg 2007; 109:125-131.
50. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003;34:1364-1369.
51. Lanthier S, Lortie A, Michaud J, et al. Isolated angiitis of the CNS in children. Neurology 2000; 56:837-842.
52. Goodwin FC, Beattie RM, Millar J, Kirkham FJ. Celiac disease and childhood stroke. Pediatr Neurol 2004; 31:139-142.
53. Lees KR, Zivin JA, Ashwood A, et al. Stroke-acute ischemic NXY treatment (SAINT I) trial investigators. N Engl J Med 2006; 354:588-600. This study examined a potential acute therapy for adult AIS - NXY-059 (free radical scavenger and its effects on cytokines - with promising results.
54. Ferro JM, Davalos A. Other neuroprotective therapies on trial in acute stroke. Cerebrovasc Dis 2006; 21 (Suppl 2):127-130.
55. Janjua N, Nasar A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children: data from the nationwide sample. Stroke 2007; 38:1850-1854. This study found that although thrombolytic therapy is not currently indicated for pediatric patients, it is being administered. More data on the outcomes of thrombolysis in children are needed.
56. Amlie-Lefond C, Benedict SL, Bernard T, et al. Thrombolysis in children with arterial ischemic stroke: initial results from the International Pediatric Stroke Study. Stroke 2007; 38:485.
57. Grigoriadis S, Gomori JM, Grigoriadis N, Cohen JE. Clinically successful late recanalization of basilar artery occlusion in childhood: what are the odds? Case report and review of the literature. J Neurol Sci 2007; 260:256-260.
58. Gordon A, Connelly A, Neville B, et al. Modified constraint-induced movement therapy after childhood stroke. Dev Med Child Neurol 2007; 49:23-27. Examination of a relatively new and promising rehabilitative strategy for pediatric AIS patients with hemiparesis in which the unimpaired upper limb is restrained and the impaired upper limb is intensively trained.
59. Pavlakis SG, Hirtz DG, DeVeber G. Pediatric stroke: opportunities and challenges in planning clinical trials. Pediatr Neurol 2006; 34:433-435. This was a review of recommendations toward advancing pediatric stroke research.